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Mitochondrial trafﬁckingUnderstanding speciﬁc cargo distribution in differentiated cells is a major challenge. Trafﬁcking
kinesin proteins (TRAKs) are kinesin adaptors. They bind the cargo binding domain of kinesin-1
motor proteins forming a link between the motor and their cargoes. To reﬁne the TRAK1/2 binding
sites within the kinesin-1 cargo domain, rationally designed C-terminal truncations of KIF5A and
KIF5C were generated and their co-association with TRAK1/2 determined by quantitative co-immu-
noprecipitations following co-expression in mammalian cells. Three contributory regions forming
the TRAK2 binding site within KIF5A and KIF5C cargo binding domains were delineated. Differences
were found between TRAK1/2 with respect to association with KIF5A.
Structured summary of protein interactions:
TRAK2 physically interacts with KIF5C by anti tag coimmunoprecipitation (View interaction)
TRAK1 physically interacts with KIF5A by anti tag coimmunoprecipitation (View interaction)
TRAK2 physically interacts with KIF5A by anti tag coimmunoprecipitation (1, 2)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction of proteins (reviewed in [1]). The molecular basis of the interactionThe kinesins are motor proteins that mediate the transport of
organelles and protein complex cargoes within cells. Kinesin-1,
the ﬁrst kinesin to be identiﬁed, is a heterotetramer consisting of
two heavy chains and two light chains. The heavy chains are com-
prised of three domains, the motor domain, the stalk domain and
the C-terminal cargo binding domain. Although some cargoes asso-
ciate directly with kinesin via the cargo binding domain or via the
light chains, others, particularly those expressed in the central ner-
vous system, associate with kinesin adaptor proteins which then
bind to the cargo domain to form trafﬁcking complexes (reviewed
in [1]). Known kinesin-1 adaptor proteins include syntabulin, glu-
tamate receptor-interacting protein 1 (GRIP1), UNC76, fascicula-
tion and elongation protein-f (FEZ1), adaptor protein mitogen-
activated protein kinase-activating death domain (MADD also
known as DENN) and the trafﬁcking kinesin (TRAK)/Milton familybetween kinesin and the adaptor proteins is not known.
The TRAK family of kinesin adaptor proteins consists of TRAK1
and TRAK2. TRAKs bind to the cargo binding domain of conven-
tional kinesin-1 heavy chains forming a link between the motor
protein and cargo [2–4]. Milton is the Drosophila species homo-
logue of TRAK1 and TRAK2 [5]. Huntingtin-associated protein-1
(HAP1) may also be a member of the TRAK family since it has
47% homology with both TRAK1 and TRAK2 within a 297 amino
acid stretch within the N-terminal domain [6]. HAP1 however has
been shown to bind kinesin light chains [7]. The most well estab-
lished cargo known to be transported by the TRAK/Milton family
are mitochondria as a result of the association of TRAK1 and TRAK2
with Miro1 and Miro2, outer mitochondrial membrane, atypical
Rho GTPases [8–12]. The expression of a dominant negative TRAK2
construct that inhibited the binding of kinesin-1 to TRAK1 and
TRAK2 in primary cultures of hippocampal neurons, resulted in de-
creased axonal mitochondrial transport [4]. Similarly, shRNA gene
knock-down of TRAK1 also arrested axonal mitochondrial mobility.
shRNA gene knock-down of TRAK2 however was without effect [4].
Recently it was found that whereas TRAK1 functions as an adaptor
in axons, TRAK2 is requisite for mitochondrial transport in den-
drites [12]. This ﬁnding thus explains the mismatch between the
dominant negative and shRNA ﬁndings reported by Stephenson
and Brickley [4] and at the same time suggests that there may be
differences between the interactions of the two major TRAK family
members with kinesin-1 and mitochondrial cargoes.
3764 T.S. Randall et al. / FEBS Letters 587 (2013) 3763–3769We have previously shown that TRAK2 co-immunoprecipitates
in the brain with the KIF5A kinesin-1 subtype [2]. Using the proto-
typic kinesin-1, KIF5C, and a combination of co-immunoprecipita-
tions with KIF5C constructs, yeast two-hybrid interaction assays
and Förster resonance energy transfer (FRET) studies using yellow
and cyan ﬂuorescent protein tagged constructs, we showed that
both TRAK1 and TRAK2 bind directly to the KIF5C cargo binding
domain [3,13]. Using a co-immunoprecipitation strategy, we have
now extended these studies to reﬁne further the TRAK1 and TRAK2
binding regions within KIF5A, the endogenous neuronal kinesin-1
with which TRAK2 associates, and also KIF5C.
2. Materials and methods
2.1. Constructs
Mammalian expression KIF5A and KIF5C constructs were generated
following PCR ampliﬁcation of respective parent human cDNAs. KIF5A
and KIF5C PCR products were sub-cloned in frame into pcDNA4HisMax
(pcDNA) toyieldproteinproducts containinganN-terminalHis-tag. Final
constructs were as follows: pcDNAKIF5A, pcDNAKIF5A1-961 (pcDNAKI-
F5AD962-1032), pcDNAKIF5A1-942 (pcDNAKIF5AD943-1032), pcDNAKIF5A1-
909 (pcDNAKIF5AD910-1032), pcDNAKIF5A1-885(pcDNAKIF5AD886-1032),
pcDNAKIF5A1-883 (pcDNAKIF5AD884-1032), pcDNAKIF5A1-881 (pcDNAKI-
F5AD882-1032), pcDNAKIF5A1-879 (pcDNAKIF5AD880-1032), pcDNAKIF5A1-Fig. 1. Schematic diagram and amino acid sequence alignment of KIF5A, KIF5B and KIF
domains of the kinesin-1 family members, KIF5A, KIF5B and KIF5C. (B) Schematic represe
study. (C) An alignment of the amino acid sequences of the human KIF5A (Protein acces
(Protein accession number: NP004513) cargo binding domains. Identical amino acids are
the positions of KIF5A and KIF5C truncations respectively.877 (pcDNAKIF5AD878-1032), pcDNAKIF5A1-861 (pcDNAKIF5AD862-1032),
pcDNAKIF5A1-825 (pcDNAKIF5AD826-1032), pcDNAKIF5C, pcDNAKIF5C1-
889 (pcDNAKIF5CD890-957), pcDNAKIF5C1-881 (pcDNAKIF5CD882-957) and
pcDNAKIF5C1-828(pcDNAKIF5CD829-957).Deletionmutagenesisbyoverlap
extensionPCRwasused togeneratepcDNAKIF5AD877-883 (i.e. aminoacids
877–883, have been deleted). pCMVTRAK2 (rat) was generated as in [6];
recombinantTRAK2hasaC-terminalFlag-tag.pCMVTRAK1(human)was
as in [2]; recombinant TRAK1 has a C-terminal c-Myc tag.
2.2. Antibodies
Primary anti-His-tag antibodies conjugated to horseradish per-
oxidase were from Sigma–Aldrich (Gillingham, Dorset, UK); anti-
FLAG antibodies were as in [6]; anti-c-Myc antibodies were from
Thermo Fisher Scientiﬁc (Massachusetts, USA). Rabbit and mouse
horseradish peroxidase-linked secondary antibodies were from
Amersham Biosciences (UK).
2.3. Mammalian cell transfections, immunoprecipitations and
immunoblotting
Human embryonic kidney (HEK) 293 cells were transiently trans-
fected with pCMVTRAK2 or pCMVTRAK1 with either pcDNAKIF5A,
pcDNAKIF5A truncations, pcDNAKIF5AD877-883, pcDNAKIF5C or
pcDNAKIF5C truncation constructs in equal ratios by the calcium5C kinesin-1 subtypes. (A) Schematic depicting the motor, stalk and cargo binding
ntations of the epitope-tagged KIF5A, KIF5C, TRAK1 and TRAK2 proteins used in this
sion number: NP004975), KIF5B (Protein accession number: NP004512) and KIF5C
highlighted in black; amino acid similarities are highlighted in grey. ⁄ and N show
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transfection. TritonX-100 (1%v/v) extractswereprepared and centri-
fuged at 100,000g to yield solubilised extracts of transfected HEK
293 cells. Immunoprecipitations were carried out using either anti-
FLAG, anti-c-Myc antibodies or non-immune Ig. Immunepelletswere
precipitated by the addition of protein A Sepharose and analysed by
immunoblottingusing anti-FLAG, anti-c-Myc and anti-His antibodies
as appropriate as previously described (e.g. [14]). Note that for all
immunoblots, 10% of the immune and non-immune pellets were
probed with the precipitating antibody whereas 90% of the immune
and non-immune pellets were probed with the appropriate antibod-
ies that were used to determine co-precipitation. Immunoblots were
quantiﬁed by band densitometry analysis using GeneTools™ soft-
ware. Statistical analysis was carried out using a paired students t-
test and signiﬁcance given as ⁄P < 0.05, ⁄⁄P < 0.01 and ⁄⁄⁄P < 0.001.
3. Results and discussion
3.1. TRAK2 co-immunoprecipitates with the KIF5A cargo binding
domain
TRAK2 was shown previously to associate directly with the
KIF5C cargo binding domain [3] but, since TRAK2 associates with
KIF5A in native tissue, in the ﬁrst instance it was investigated if
TRAK2 also binds to the KIF5A cargo binding domain. A comparisonFig. 2. Association of TRAK2 with KIF5A, KIF5A1-825 and KIF5A1-961: demonstration by c
either pcDNAKIF5A, pcDNAKIF5A1-825 or pcDNAKIF5A1-961. Cell homogenates were pre
carried out using either anti-FLAG antibodies or non-immune Ig. (A and C) Representati
1 = transfected HEK 293 detergent-solubilized cell homogenates; lane 2 = non-immune
positions of molecular mass standards (kDa) are shown on the right. (B and D) Histog
immunoreactivities of the respective immune pellets to detergent solubilized input were
KIF5AHIS transfectants = 100%). Immunoblots are representative of at least n = 3 co-
Means ± S.E.M. for at least n = 3 co-immunoprecipitations from at least n = 3 independenof the three kinesin-1 isoforms, KIF5A, KIF5B and KIF5C are shown
in Fig. 1 together with the tagged constructs generated. Thus,
KIF5A was truncated at 825 which resulted in the deletion of the
C-terminal cargo binding domain generating an N-terminally His-
tagged construct, KIF5A1-825. This was co-expressed with C-termi-
nal FLAG-tagged TRAK2 in HEK 293 cells in parallel with wild-type
TRAK2/KIF5A co-transfectants. Transfected cells were harvested,
solubilized, immunoprecipitated with anti-FLAG or non-immune
Ig and immune precipitates were analysed by quantitative immu-
noblotting. The results are shown in Fig. 2. For both transfection
conditions, anti-FLAG but not control non-immune antibodies
immunoprecipitated a major molecular weight species of Mr -
 110 kDa consistent with the size of TRAK2 (Fig. 2A). Immuno-
blotting with anti-His antibodies revealed the presence of KIF5A,
Mr  100 kDa in immunoprecipitates from wild-type TRAK2FLAG/
KIF5AHis transfectants. However, deletion of the C-terminal cargo
binding domain resulted in the loss of anti-His immunoreactivity
in immune pellets (Fig. 2C). Thus similarly to KIF5C, TRAK2 binds
to the KIF5A cargo binding domain.
KIF5A has an extended C-terminal region compared to KIF5B
and KIF5C (Fig. 1). To determine the signiﬁcance of this region in
terms of TRAK2 binding, this was deleted to generate KIF5A1-961
and transfections and immunoprecipitations were carried out as
above always in parallel with wild-type TRAK2FLAG and KIF5AHis.
Deletion of KIF5A 962–1032 amino acids had no qualitative effecto-immunoprecipitation. HEK 293 cells were co-transfected with pCMVTRAK2 and
pared 48 h post-transfection, detergent solubilised and co-immunoprecipitations
ve immunoblots of immune pellets. For this and all subsequent immunoblots, lane
pellet and lane 3 = anti-FLAG pellet. ?, the position of immunoreactive bands. The
rams showing the quantitative analyses of co-immunoprecipitations. The ratios of
determined and expressed as percentages of the control (i.e. wild-type TRAK2FLAG/
immunoprecipitations from at least n = 3 independent transfections. (B and D
t transfections. ⁄P < 0.05; ⁄⁄⁄P < 0.001.
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pared to wild-type (Fig. 2C). However, quantitative analyses of
the co-immunoprecipitations revealed that removal of the ex-
tended KIF5A tail resulted in an increased (70%) efﬁciency of
TRAK2/KIF5A1-961 association. This implies that the KIF5A tail
may be important in regulating the efﬁcacy of TRAK2/KIF5A asso-
ciation. Note that the efﬁciency of TRAK2 immunoprecipitation is
not affected by the co-expression of the different KIF5A constructs
(Fig. 2B).
3.2. Reﬁnement of the TRAK2 binding region of KIF5A
To reﬁne the TRAK2 binding site within the KIF5A cargo binding
domain, a series of KIF5A truncations were generated. Each was co-
expressed with TRAK2 and immunoprecipitation assays carried out
as above to determine if the truncated constructs retained the abil-
ity to co-immunoprecipitate with TRAK2. The rationale for the site
of the KIF5A truncations was based on the amino acid sequence
similarities and differences between the three kinesin-1 isoforms.
The C-terminal region 20 amino acids of KIF5B and KIF5C and
the corresponding aligned region of KIF5A is variable thus
KIF5A1-942 was designed to delete this region. KIF5A1-942 retained
the ability to co-immunoprecipitate with TRAK2 albeit with a re-
duced efﬁciency; the percentage KIF5A1-942 co-immunoprecipi-
tated with TRAK2 was signiﬁcantly reduced, 40%, compared to
wild-type TRAK2/KIF5A transfections (Fig. 3D). Further truncations
at KIF5A 909 and KIF5A 885 resulted in no additional decrease in
the co-immunoprecipitation efﬁciency compared to KIF5A 942Fig. 3. Reﬁnement of the KIF5A TRAK2 binding site. HEK 293 cells were co-transfecte
pcDNAKIF5A1-885, pcDNAKIF5A1-861 (A–D) or pcDNAKIF5A, pcDNAKIF5A1-883, pcDNAKIF5
48 h post-transfection, detergent solubilised and immunoprecipitations carried out usin
immunoblots of the immune pellets with gel lanes as in Fig. 2.?, the position of immun
immunoprecipitations. The ratios of immunoreactivities of the respective immune pellets
control (i.e. wild-type TRAK2FLAG/KIF5AHIS transfectants = 100%). Immunoblots are repre
transfections. C, D, G and H D, means ± S.E.M. for at least n = 3 co-immunoprecipitationtruncations. Truncation at KIF5A 861 however resulted in the loss
of co-immunoprecipitation with TRAK2 implying that the highly
conserved region KIF5A numbering 825–861, does not contribute
to the binding of TRAK2 (Fig. 3D). It was notable that a small but
signiﬁcant co-immunoprecipitation (10%) was detected for con-
structs truncated at KIF5A 877; this was statistically signiﬁcantly
different to the percentage KIF5A co-immunoprepicipated with
TRAK2 for constructs KIF5A1-942; KIF5A1-909 and KIF5A1-885
(Fig. 3D). Thus using this approach, three regions within the KIF5A
C-terminal region were shown to contribute to the TRAK2 binding
site i.e. KIF5A 942–961; KIF5A 877–885 and KIF5A 861–877. (Note
that full immunoblots for Figs. 3–5 can be viewed in the Supple-
mentary Information, Figs. S1–S3).
The region KIF5A 877–883 was studied in more detail. Three
additional truncations were made at KIF5A 883, KIF5A 881 and
KIF5A 879 plus the region 877–883 was deleted. The constructs
truncated at KIF5A 883, KIF5A 881 and KIF5A 879 co-immunopre-
cipitated with TRAK2 with a similar efﬁciency to KIF5A1-885 as in-
deed did the KIF5AD877-883 deletion. The latter was unexpected
since this region, amino acid sequence GALKEAKE, had been clearly
implicated in the efﬁciency of KIF5A/TRAK2 association (Fig. 3D). It
may be explained by an alteration of the KIF5A tertiary structure
such that other amino acids requisite for the binding of TRAK2
are now available to compensate for the deleted region thus the
predicted loss in efﬁcacy of co-immunoprecipitation is circum-
vented. In the context of the full length KIF5A therefore, the other
sites of interaction are sufﬁcient to support partial association with
TRAK2 even when 877–883 is removed.d with pCMVTRAK2 and either pcDNAKIF5A, pcDNAKIF5A1-942, pcDNAKIF5A1-909,
A1-881, pcDNAKIF5A1-879, pcDNAD877-883 (E and F). Cell homogenates were prepared
g either anti-FLAG antibodies or non-immune Ig. A, B, E and F are representative
oreactive bands. C, D, G and H, histograms showing the quantitative analyses of co-
to detergent solubilized input were determined and expressed as percentages of the
sentative of at least n = 3 co-immunoprecipitations from at least n = 3 independent
s from at least n = 3 independent transfections. ⁄P < 0.05; ⁄⁄⁄P < 0.001.
Fig. 4. Association of TRAK2 with KIF5C: demonstration by co-immunoprecipitation. HEK 293 cells were co-transfected with pCMVTRAK2 and either pcDNAKIF5C,
pcDNAKIF5C1-889, pcDNAKIF5C1-881 or pcDNAKIF5C1-828. Cell homogenates were prepared 48 h post-transfection, detergent solubilised and immunoprecipitations carried out
using either anti-FLAG antibodies or non-immune Ig. (A and C) Representative immunoblots of the immune pellets with gel lanes as in Fig. 2. ?, the position of
immunoreactive bands. (B and D) Histograms showing the quantitative analyses of co-immunoprecipitations. The ratios of immunoreactivities of the respective immune
pellets to detergent solubilized input were determined and expressed as percentages of the control (i.e. wild-type TRAK2FLAG/KIF5CHIS transfectants = 100%). Immunoblots are
representative of at least n = 3 co-immunoprecipitations from at least n = 3 independent transfections. ⁄P < 0.05; ⁄⁄⁄P < 0.001.
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and KIF5C?
To determine if there are any differences in the interaction of
TRAK2 between KIF5A and KIF5C, similar experiments were carried
out using KIF5C constructs. We have previously shown that the
KIF5C non-motor domain co-immunoprecipitated with TRAK2 [3]
suggesting that TRAK2 bound to the KIF5C cargo binding domain.
Here, we deleted the KIF5C cargo binding domain and found that
KIF5C1-828 lost the ability to be co-immunoprecipitated by TRAK2
(Fig. 4). Thus these deletion construct experiments are in agreement
with those employing isolated domains, i.e. TRAK2 does indeed bind
to the KIF5C cargo binding region. Two additional KIF5C truncations
were generated KIF5C1-881 which corresponds to KIF5A1-877 and
KIF5C1-889 which aligns with KIF5A1-885 (Fig. 1). A similar overall
proﬁle was obtained. TRAK2 co-immunoprecipitated KIF5C1-881
with an efﬁciency of 10% compared to wild-type KIF5C; the efﬁ-
ciency of KIF5C1-889 co-immunoprecipitation by TRAK2was also re-
duced. No signiﬁcant difference in immunoprecipitation efﬁciencies
between KIF5A1-885 and KIF5C1-881 was detected. Values for the de-
creased efﬁciency of co-immunoprecipitation were: 70.1 ± 12.3%
(KIF5C1-881) and 60.2 ± 12.3% (KIF5A1-885); P < 0.01.Thus the TRAK2
binding sites of KIF5A and KIF5C are similar.
3.4. KIF5A discriminates between TRAK1 and TRAK2 with respect to
binding speciﬁcity
Differences between the interaction of TRAK1 and TRAK2 with
kinesin motor proteins were recently reported [12]. It was thus
of relevance to determine if TRAK1 had a similar binding proﬁle
to that of TRAK2 for the KIF5A truncations that have been studiedhere. Thus an N-terminally c-Myc tagged-TRAK1 was co-expressed
with KIF5A1-961, KIF5A1-879, KIF5A1-877 and KIF5A1-825 in parallel
with wild-type TRAK1/KIF5A combinations; co-immunoprecipita-
tions were carried out as before except that anti-c-Myc antibodies
were used as the primary precipitating antibody. The results are
shown in Fig. 5. Interestingly, the TRAK1 co-immunoprecipitation
proﬁle was in marked contrast to that observed for TRAK2. Re-
moval of the extended C-terminal KIF5A tail did not result in en-
hanced co-immunoprecipitation. TRAK1 retained the ability to
co-immunoprecipitate KIF5A in the absence of the cargo binding
domain albeit with a reduced efﬁciency of 15 ± 11% (n = 3). Further,
no decrease in co-immunoprecipitation efﬁciency was evident for
the KIF5A1-881 and KIF5A1-877 truncations. Note that as for the
TRAK2 immunoprecipitation assays, the efﬁciency of TRAK1 immu-
noprecipitations is not affected by the co-expression of the differ-
ent KIF5A constructs (Fig. 5).
3.5. Conclusions
In this paper, we have reﬁned the TRAK2 binding site within the
kinesin-1 cargo binding domain of the molecular motor, KIF5A. We
have shown that there are three contributing regions of KIF5A to
the binding site for TRAK2. Our data show that, as these regions
are sequentially truncated from the motor’s C-terminal end, the
interaction between the motor and its adaptor is gradually re-
duced. However, deletion of an exemplar individual region (KIF5A
877–883) only modestly reduced the interaction. This supports the
idea that the KIF5A–TRAK2 interaction is multivalent and could act
to ensure stable motor-cargo interaction during intracellular traf-
ﬁcking; dimerization of both motor and adaptor molecules further
enhances this stability (Fig. 6). A similar multivalent proﬁle was
Fig. 5. Association of TRAK1 with KIF5A: demonstration by co-immunoprecipitation. HEK 293 cells were transfected with pCMVTRAK1 and either pcDNAKIF5A,
pcDNAKIF5A1-961, pcDNAKIF5A1-879, pcDNAKIF5A1-877 or pcDNAKIF5A1-825. Cell homogenates were prepared 48 h post-transfection, detergent solubilised and immunopre-
cipitations carried out using either anti-c-Myc antibodies or non-immune Ig. (A and C) Representative immunoblots of the immune pellets with gel lanes as in Fig. 2.?, the
position of immunoreactive bands. (B and D) Histograms showing the quantitative analyses of co-immunoprecipitations. The ratios of immunoreactivities of the respective
immune pellets to detergent solubilized input were determined and expressed as percentages of the control (i.e. wild-type TRAK1C-Myc/KIF5AHIS transfectants = 100%).
Immunoblots are representative of at least n = 3 co-immunoprecipitations from at least n = 3 independent transfections. (B and D) Means ± S.E.M. for at least n = 3 co-
immunoprecipitations from at least n = 3 independent transfections. ⁄⁄P < 0.01.
Fig. 6. A schematic diagram depicting the association between TRAK2 and kinesin-1. (A) Is a schematic diagram of the kinesin-1/TRAK/Miro mitochondrial trafﬁcking
complex. (B) Illustrates the three KIF5A regions that were identiﬁed in this paper as contributing to the TRAK2 binding domain.
3768 T.S. Randall et al. / FEBS Letters 587 (2013) 3763–3769found for the TRAK2 binding site within the kinesin-1 isoform,
KIF5C. We also observed that the unique KIF5A C-terminal se-
quence was not required for TRAK binding. In fact, removal of thisregion enhanced the interaction between KIF5A and TRAK2
suggesting that isoform-speciﬁc auto-inhibition may provide a fur-
ther layer of transport regulation by neuronal kinesins.
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distinct to that of TRAK2 suggesting a differential interaction be-
tween these two kinesin adaptor proteins and molecular motors
which may impact in the determination and selectivity of cargo
binding and delivery within neurons. In fact, we had previously
found that TRAK1 behaved differently to TRAK2 in terms of associ-
ation with kinesin-1 isoforms [2]. TRAK1 and TRAK2 both co-
immunoprecipitated with endogenous KIF5B and exogenous KIF5C
following expression in HEK 293 cells. In yeast two-hybrid interac-
tion assays however, TRAK1 ﬁsh constructs did not result in repor-
ter gene activity following co-transformation with a KIF5C bait.
This was in contrast to TRAK2/KIF5C bait/ﬁsh combinations where
robust reporter gene expression was evident for both full length
TRAK2 and TRAK2124-283, the kinesin-1 binding domain [2]. The
equivalent TRAK1 region, TRAK1124-283, to the TRAK2124-283 kine-
sin-1 binding domain, did not co-immunoprecipitate with full
length KIF5C again in contrast to TRAK2124-283/KIF5C co-expression
and co-immunoprecipitation. This suggests that TRAK1 may adopt
different conformational states that lead to the observed perplex-
ing inconsistencies. Interestingly, van Spronsen et al. [12] also re-
ported differences between TRAK1 and TRAK2 in terms of their
respective association with kinesin-1. In contrast to Brickley
et al. [2], they found that TRAK2 did not associate with endogenous
KIF5B in HEK 293 cells. Furthermore, only TRAK1 was shown to
have a strong interaction with kinesin-1 in rat brain [12]. These
ﬁndings were explained by FRET acceptor photobleaching experi-
ments which suggested that TRAK2 forms a stable head to tail di-
mer whereas TRAK1 has a more dynamic and transient
conformation. These conformational differences were speculated
to contribute to different cargo binding capabilities and targeting
i.e. TRAK1 mediates mitochondrial transport in axons, whereas
TRAK2 is the major adaptor in dendrites [4,12]. The discrepancies
between the two groups are yet to be explained.
Recently, Chen and Sheng [15] reported that syntaphilin, a pro-
tein shown to anchor axonal mitochondria, competes with TRAK2
for the binding to kinesin-1 (KIF5C). They further reported that co-
expression of TRAK2 with microtubules and KIF5C resulted in an
enhanced KIF5 motor ATPase activity [15]. The latter observation
suggests that the binding of TRAK2 within the cargo binding region
inﬂuences the N-terminal motor activity of kinesin-1 presumably
via conformational changes. The competition between syntaphilin
and TRAK2 for the binding to kinesin implies that at least in part,
they share a common KIF5 binding site. It would be interesting
to test the ability of the KIF5A truncations generated here for their
ability to co-immunoprecipitate syntaphilin.
The structure of the kinesin non-motor domain has so far been
experimentally intractable presumably in part because of difﬁcul-
ties in crystallization explained perhaps by intrinsic ﬂexibility [16].
However, a complex between kinesin-1 motor dimer and an auto-
inhibitory portion of the kinesin-1 tail domain has been structur-
ally characterised, providing insight into the molecular basis of
kinesin transport efﬁciency [17]. Strikingly, the motor tail peptide
responsible for blockage of motor activity (KIF5B 937–952, includ-
ing the well-characterised and completely conserved IAK sequence
[18,19] is located in between two of the sites of kinesin-TRAK
interaction that we have identiﬁed. Thus, an auto-inhibited kinesin
molecule would not be expected to be accessible for TRAK binding
or available for transport, whereas binding to a TRAK adaptor
would be expected to activate kinesin motility.
The studies described and cited herein support functional cross-
talk between the motor and cargo binding non-motor domains and
they identify three regions that are important for at least one fam-
ily of kinesin adaptor protein, the TRAKs. It remains to be estab-
lished if the same determinants mediate the binding of other
kinesin adaptors (including syntaphilin) or, alternatively, they bind
to other regions. This could provide a molecular basis for the dis-crimination of kinesin/kinesin adaptor protein/cargo speciﬁcity
ultimately deﬁning mechanisms of differential intracellular
transport.
Acknowledgements
This work was funded by the BBSRC (UK). TSR held a Blooms-
bury Consortium PhD studentship. We would like to thank Dr Sar-
ah L Cousins for transfections of HEK 293 cells; Nicholas
Hadjisavvas for assistance in the generation of the truncated KIF5C
clones and Drs Kieran Brickley and Sarah L Cousins for expert,
insightful discussions.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2013.09.
049.
References
[1] Hirokawa, N., Noda, Y., Tanaka, Y. and Niwa, S. (2009) Kinesin superfamily
motor proteins and intracellular transport. Nat. Rev. Cell Biol. 10, 682–696.
[2] Brickley, K., Smith, M.J., Beck, M. and Stephenson, F.A. (2005) GRIF-1 and
OIP106, members of a novel gene family of coiled-coil domain proteins:
association in vivo and in vitro with kinesin. J. Biol. Chem. 280, 14723–14732.
[3] Smith, M.J., Pozo, K., Brickley, K. and Stephenson, F.A. (2006) Mapping the
GRIF-1 binding domain of the kinesin, KIF5C, substantiates a role for GRIF-1 as
an adaptor protein in the anterograde trafﬁcking of cargoes. J. Biol. Chem. 281,
27216–27228.
[4] Brickley, K. and Stephenson, F.A. (2011) TRAK-mediated transport of
mitochondria in axons of hippocampal neurons. J. Biol. Chem. 286, 18079–
18092.
[5] Stowers, R.S., Megeath, L.J., Gorska-Andrzejak, J., Meinertzhagen, I.A. and
Schwarz, T.L. (2002) Axonal transport of mitochondria to synapses depends on
Milton, a novel Drosophila protein. Neuron 36, 1063–1077.
[6] Beck, M., Brickley, K., Wilkinson, H., Sharma, S., Smith, M., Chazot, P.L., Pollard,
S. and Stephenson, F.A. (2002) Identiﬁcation, molecular cloning and
characterization of a novel GABAA receptor associated protein, GRIF-1. J.
Biol. Chem. 277, 30079–30090.
[7] McGuire, J.R., Rong, J., Li, S.-H. and Li, X.-J. (2005) Interaction of Huntingtin-
associated protein-1 with kinesin light chain. J. Biol. Chem. 281, 3552–3559.
[8] Fransson, A., Ruusala, A. and Aspenstrom, P. (2006) The atypical Rho GTPases
Miro-1 and Miro-2 have essential roles in mitochondrial trafﬁcking. Biochem.
Biophys. Res. Commun. 344, 500–510.
[9] MacAskill, A.F., Brickley, K., Stephenson, F.A. and Kittler, J.T. (2009) GTPase
dependent recruitment of GRIF-1by Miro1 regulates mitochondrial trafﬁcking
in hippocampal neurons. Mol. Cell. Neurosci. 40, 301–312.
[10] Wang, X. and Schwartz, T.L. (2009) The mechanism of Ca2+-dependent
regulation of kinesin-mediated mitochondrial motility. Cell 136, 163–174.
[11] Koutsopoulos, O.S., Laine, D., Osellame, L., Chudakov, D.M., Parton, R.G.,
Frazier, A.E. and Ryan, M.T. (2010) Human Miltons associate with
mitochondria and induce microtubule-dependent remodeling of
mitochondrial networks. Biochim. Biophys. Acta 1803, 564–574.
[12] van Spronsen, M., Mikhaylova, M., Lipka, J., van den Schlager, M.A., Heuvel, D.J.,
Kuijpers, M., Wulf, P.S., Keijzer, N., Demmers, J., Kapitein, L.C., Jaarsma, D.,
Gerritsen, H.C., Akhmanova, A. and Hoogenraad, C.C. (2013) TRAK/Milton
motor-adaptor proteins steer mitochondrial trafﬁcking to axons and
dendrites. Neuron 77, 485–502.
[13] Brickley, K., Pozo, K. and Stephenson, F.A. (1813) (2011) N-Acetylglucosamine
transferase is an integral component of a kinesin-directed mitochondrial
trafﬁcking complex. Biochim. Biophys. Acta 1, 269–281.
[14] Cousins, S.L. and Stephenson, F.A. (2012) Identiﬁcation of NMDA receptor
subtype-speciﬁc binding sites that mediate direct interactions with the
scaffold protein, PSD-95. J. Biol. Chem. 287, 13465–13476.
[15] Chen, Y. and Sheng, Z.-H. (2013) Kinesin-1-syntaphilin coupling mediates
activity-dependent regulation of axonal mitochondrial transport. J. Cell Biol.
202, 351–364.
[16] Seeger, M.A., Zhang, Y. and Rice, S.E. (2012) Kinesin tail domains are
intrinsically disordered. Proteins 80, 2437–2446.
[17] Kaan, H.Y.K., Hackney, D.D. and Kozielski, F. (2011) The structure of the
kinesin-1 motor-tail complex reveals the mechanism of autoinhibition.
Science 333, 883–885.
[18] Hackney, D.D. and Stock, M.F. (2000) Kinesin’s IAK tail domain inhibits initial
microtubule-stimulated ADP release. Nat. Cell Biol. 2, 257–260.
[19] Hackney, D.D., Baek, N. and Snyder, A.C. (2009) Half-site inhibition of dimeric
kinesin head domains by monomeric tail domains. Biochemistry 48, 3448–
3456.
